References
| Author (yr) | Title | Citation | Isolate |
|---|---|---|---|
| Gerstenberg (2024) | Therapeutic Drug Monitoring of Long-Acting Rilpivirine and Cabotegravir for Treatment of HIV-1 Infection-A Case Series of Five Patients With One Virologic Failure After Development of Two-Class Resistance. | Open Forum Infect Dis | PR HIV1 group M: 3 RT HIV1 group M: 3 IN HIV1 group M: 3 |
